Inherited BMF Syndrome

4

Review clinical trials related to Inherited BMF Syndrome. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT

The major morbidities of allogeneic hematopoietic stem cell transplant (HSCT) using donors that are not human leukocyte antigen (HLA) matched siblings are graft vs host disease (GVHD) and life- threatening infections. T cell receptor alpha beta (TCRαβ) T lymphocyte depletion and CD19+ B lymphocyte depletion of alternative donor hematopoietic stem cell (HSC) grafts is effective in preventing GVHD, but immune reconstitution may be delayed, increasing the risk of infections. The central hypothesis of this study is that an addback of CD45RO memory T lymphocytes, derived from a fraction of the original donor peripheral stem cell product depleted of CD45RA naïve T lymphocytes, will accelerate immune reconstitution and help decrease the risk of infections in TCRab/CD19 depleted PSCT.

Participants needed: 100
Trial details
Phase: Phase 1, Phase 2Age: 1-25Biological sex: AllType: InterventionalSponsor: Children's Hospital of PhiladelphiaUpdated: Apr 15, 2026Locations: 1
Eligibility criteria

Disease for which allogeneic HSCT may be curative. [+5]

Patients who have performance score less than 60. [+15]

Status: Recruiting

Shwachman-Diamond Syndrome Global Patient Survey and Partnering Platform

The Shwachman-Diamond Syndrome Global Patient Survey and Collaboration Program (SDS-GPS) is an opportunity for patients and their families - from anywhere in the world - to share their experience living with SDS via a safe, secure, and convenient online platform, to * expand the understanding of SDS * improve the lives of people with SDS, and * accelerate the development of new therapies and cures for SDS. By joining, participants will receive early access to relevant information about new clinical trials and other research opportunities (such as clinical registries) based on their profile, accelerating research and increasing clinical trial impact and recruitment success. The platform, consent forms, and surveys are available in five languages: English, Spanish, French, German, and Italian. More languages to come.

Participants needed: 8,000
Trial details
Biological sex: AllType: ObservationalSponsor: Shwachman-Diamond Syndrome Alliance IncUpdated: May 31, 2025Locations: 1Duration: 120 Years
Eligibility criteria

Patients with a confirmed Shwachman-Diamond Syndrome (SDS) diagnosis, including... [+3]

Status: Recruiting

Diagnosis and Phenotype Characterisation Using Genomics in Patients With Inherited Bone Marrow Failure (IBMDx Study)

This project seeks to perform whole genome sequence (WGS) and whole transcriptome sequence (WTS) analysis on 350 patients with suspected inherited bone marrow failure syndromes and related disorder (IBMFS-RD) in order to increase the genomic diagnostic rate in IBMFS.

Participants needed: 350
Trial details
Age: 3+Biological sex: AllType: ObservationalSponsor: Peter MacCallum Cancer Centre, AustraliaUpdated: Nov 7, 2024Locations: 1
Eligibility criteria

age ≥ 3 months [+2]

A clinicopathological diagnosis of an acquired bone marrow failure syndrome (inc... [+1]

Status: Recruiting

Mutations and Phenotypes of Unclassifiable Inherited Bone Marrow Failure Syndromes

Inherited bone marrow failure syndromes (IBMFSs) are a diverse collection of genetic illnesses characterized by various degrees of peripheral cytopenias due to defective single-lineage or multi-lineage hematopoiesis, it can manifest itself at birth or later in life.

Participants needed: 250
Trial details
Biological sex: AllType: ObservationalSponsor: Sohag UniversityUpdated: Jul 1, 2022Locations: 1
Eligibility criteria

Confirmed a two-generational family with IBMFSs presented with signs and symptom... [+1]

• Patients will be diagnosed with paroxysmal nocturnal hemoglobinuria [+5]